A Case of Interstitial Pneumonia in Patients with Psoriasis Treated with Methotrexate / 대한피부과학회지
Korean Journal of Dermatology
; : 571-574, 2023.
Article
in En
| WPRIM
| ID: wpr-1002200
Responsible library:
WPRO
ABSTRACT
Methotrexate (MTX) is commonly employed in the management of chronic inflammatory skin diseases. We report the case of a 73-year-old man who presented with a persistent cough lasting for 1 month. He had an 11-year history of psoriasis and had received MTX (10.0 mg/wk) over the past 21 months. High-resolution chest computed tomography revealed diffuse ground-glass opacities and bronchiectasis affecting both lung fields. Based on clinical and radiological assessments, the patient was diagnosed with MTX-induced interstitial pneumonia. Notably, significant clinical and radiological improvement was observed 1 month after the discontinuation of MTX and corticosteroid administration. Although some reports have demonstrated lung toxicity in patients receiving high-dose MTX therapy, cases of adverse pulmonary effects following low-dose treatment in patients with psoriasis are rare.This case report underscores the rarity of interstitial pneumonia in a patient with psoriasis undergoing MTX treatment in Korea.
Full text:
1
Index:
WPRIM
Language:
En
Journal:
Korean Journal of Dermatology
Year:
2023
Type:
Article